S
Susan L. Stewart
Researcher at University of California, Davis
Publications - 202
Citations - 9254
Susan L. Stewart is an academic researcher from University of California, Davis. The author has contributed to research in topics: Population & Vietnamese. The author has an hindex of 47, co-authored 193 publications receiving 8395 citations. Previous affiliations of Susan L. Stewart include University of San Francisco & University of California.
Papers
More filters
Journal ArticleDOI
Factors Associated with Hepatitis B Knowledge Among Vietnamese Americans: A Population-Based Survey
Janet N. Chu,Phuoc V. Le,Phuoc V. Le,Chris J. Kennedy,Stephen J. McPhee,Ching Wong,Susan L. Stewart,Tung T. Nguyen +7 more
TL;DR: In multivariable analyses, factors associated with having heard of HBV and higher knowledge included Northern California residence, longer U.S. residence, higher education, family history ofHBV, and discussing HBV with family/friends.
Journal ArticleDOI
Alcohol, drug and other prior crimes and risk of arrest in handgun purchasers: Protocol for a controlled observational study
TL;DR: This large-scale retrospective cohort study will involve all persons who legally purchased handguns in California in 2001 and will follow-up through the end of 2013, assessing the relationships between alcohol and drug abuse and future violence among firearm owners.
Journal ArticleDOI
Patterns and co-occurrence of risk factors for hepatocellular carcinoma in four Asian American communities: a cross-sectional study.
TL;DR: Investigating risk factor patterns and the simultaneous occurrence of multiple risk factors in the viral, metabolic and lifestyle domains among Asian Americans, who have had the highest mortality rates from hepatocellular carcinoma (HCC), identified four patterns: viral (chronic HBV or HCV), lifestyle (current smoker or alcohol user, no viral); and lower risk (≤1 metabolic, no lifestyle or viral).
Journal ArticleDOI
Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response
Robert B. Rebhun,Daniel York,Sylvia M. Cruz,Sean J. Judge,Aryana M. Razmara,Lauren E Farley,Rachel Brady,Eric G. Johnson,Jenna H Burton,Jennifer L. Willcox,Luke Anthony Wittenburg,Kevin D. Woolard,Cordelia Dunai,Susan L. Stewart,Ellen E. Sparger,Sita S. Withers,Alicia A. Gingrich,Katherine A Skorupski,Sami Al-Nadaf,Amandine Lejeune,William T. N. Culp,William J. Murphy,Michael S. Kent,Robert J. Canter +23 more
TL;DR: In this first-in-dog clinical trial of inhaled rhIL-15 in dogs with advanced metastatic disease, promising clinical activity is observed when administered as a monotherapy for only 14 days, with significant clinical and biological implications for both dogs and humans with refractory lung metastases.
Journal ArticleDOI
PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery
Soner Koç,Michael Lloyd,Jeffrey Grover,Nan Xiao,Sara Seepo,Sai Lakshmi Subramanian,Manisha Ray,Christian Frech,John J. DiGiovanna,Phil Webster,Steven B. Neuhauser,B. K. Srivastava,Xing Yi Woo,Brian J. Sanderson,Brian S. White,Paul Lott,Lacey E. Dobrolecki,Heidi Dowst,Matthew A. Bailey,Emilio Cortes-Sanchez,Sandra D. Scherer,Chieh-Hsiang Yang,Maihi Fujita,Zheng-Qing Chu,Ling-Zhi Zhao,Andrew Butterfield,Argun Akcakanat,G. Boning,Kurt W. Evans,Bingliang Fang,Don L. Gibbons,V. Jensen,Dara Keener,Michael P. Kim,Scott Kopetz,Mourad Majidi,David G. Menter,John D. Minna,Hyunsil Park,Fei-yue Yang,Brenda C. Timmons,Jing Wang,Shannon N. Westin,Timothy A. Yap,Jianhua Zhang,Ran Zhang,Min Jin Ha,Huiqin Chen,Y. Xie,Luc Girard,Erkan Yucan,Bryce Kirby,Bingbing Dai,Yi Xu,Alexey V. Sorokin,Kelly Gale,Jithesh J. Augustine,Stephen Scott,Ismail M. Meraz,Dylan Fingerman,Andrew V. Kossenkov,Qing Liu,Min Xiao,Jayamanna Wickramasinghe,Haiyin Lin,Eric G. Ramírez-Salazar,Kate Nathanson,Michael T. Tetzlaff,George Xu,Vashisht Gopal Yennu-Nanda,Rebecca Aft,Jessica J. Andrews,Alicia Asaro,Song Cao,Feng Chen,Sherri R. Davies,John F. DiPersio,Ryan C Fields,Steven M. Foltz,Katherine Fuh,Kian-Huat Lim,Jason Held,Jeremy Hoog,Reyka G Jayasinghe,Yize Li,Jinqin Luo,Cynthia X. Ma,J. Mashl,Chia-Kuei Mo,Fernanda M. Rodriguez,Hua Sun,Nadezhda V. Terekhanova,Rose Tipton,B. VanTine,Andrea Wang-Gillam,Michael C. Wendl,Yige Wu,Matthew A. Wyczalkowski,Lina Yao,Daniel Cui Zhou,Matthew J. Ellis,Michael Ittmann,Susan G. Hilsenbeck,Bert O'Malley,Amanda Kirane,May Cho,David R. Gandara,Jonathan A. Reiss,Tiffany T. Le,Ralph W deVere White,Clifford G. Tepper,Dave Cooke,Luis Godoy,Lisa Brown,Marc A. Dall'Era,Christopher Evans,Rashmi Verma,Sepideh Gholami,David J. Segal,John G. Albeck,Edward Fox Pugh,Susan L. Stewart,David M. Rocke,Hongyong Zhang,Nicole B. Coggins,Ana P. Estrada,Ted Toal,Alexa Morales,Guadalupe María Polanco Echeverry,Sienna Rocha,Aihong Ma,Yvonne A. Evrard,Tiffany A. Wallace,Jeffrey A. Moscow,James H. Doroshow,Nicholas Mitsiades,Salma Kaochar,Chong-Xian Pan,Moon S. Chen,Luis G. Carvajal-Carmona,Alana L. Welm,Bryan E. Welm,Michael Lewis,Ramaswamy Govindan,Li Ding,Shunqiang Li,Meenhard Herlyn,Michael Davies,Jack A. Roth,Funda Meric-Bernstam,Peter N. Robinson,Carol J. Bult,Brandi N. Davis-Dusenbery,Dennis A. Dean,Jeffrey H. Chuang +154 more
TL;DR: The PDX net portal is of significant utility to the cancer research community as it provides a centralized location for PDXNet resources, which support multi-agent treatment studies, determination of sensitivity and resistance mechanisms, and preclinical trials.